Blueprint Medicines Drug Patent Portfolio
Blueprint Medicines owns 1 orange book drug protected by 7 US patents Given below is the list of Blueprint Medicines's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12060354 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | 08 Mar, 2042 | Active |
| US11964980 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | 10 Apr, 2040 | Active |
| US11999744 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | 10 Apr, 2040 | Active |
| US11827642 | Compositions useful for treating disorders related to KIT | 15 Oct, 2034 | Active |
| US9200002 | Compositions useful for treating disorders related to KIT | 15 Oct, 2034 | Active |
| US9944651 | Compositions useful for treating disorders related to kit | 15 Oct, 2034 | Active |
| US9994575 | Compositions useful for treating disorders related to kit | 15 Oct, 2034 | Active |
Latest Legal Activities on Blueprint Medicines's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Blueprint Medicines.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Electronic Review
Critical
| 07 Jun, 2024 | US11964980 |
| Patent eGrant Notification | 23 Apr, 2024 | US11964980 |
|
Email Notification
Critical
| 23 Apr, 2024 | US11964980 |
| Mail Patent eGrant Notification | 23 Apr, 2024 | US11964980 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Apr, 2024 | US11964980 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Apr, 2024 | US11964980 |
| Recordation of Patent eGrant | 23 Apr, 2024 | US11964980 |
|
Email Notification
Critical
| 04 Apr, 2024 | US11964980 |
|
Issue Notification Mailed
Critical
| 03 Apr, 2024 | US11964980 |
| Filing Receipt - Replacement | 21 Mar, 2024 | US11964980 |
|
Email Notification
Critical
| 21 Mar, 2024 | US11964980 |
| Dispatch to FDC | 20 Mar, 2024 | US11964980 |
|
Application Is Considered Ready for Issue
Critical
| 20 Mar, 2024 | US11964980 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 20 Feb, 2024 | US11964980 |
|
Email Notification
Critical
| 20 Feb, 2024 | US11964980 |
Blueprint Medicines's Family Patents
Blueprint Medicines drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 20.4% of its total global patent coverage. Click
below to unlock the full patent family tree.
Blueprint Medicines Drug List
Given below is the complete list of Blueprint Medicines's drugs and the patents protecting them.
1. Ayvakit
Ayvakit is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12060354 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making |
08 Mar, 2042
(16 years from now)
| Active |
| US11964980 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making |
10 Apr, 2040
(14 years from now)
| Active |
| US11999744 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making |
10 Apr, 2040
(14 years from now)
| Active |
| US11827642 | Compositions useful for treating disorders related to KIT |
15 Oct, 2034
(9 years from now)
| Active |
| US9200002 | Compositions useful for treating disorders related to KIT |
15 Oct, 2034
(9 years from now)
| Active |
| US9944651 | Compositions useful for treating disorders related to kit |
15 Oct, 2034
(9 years from now)
| Active |
| US9994575 | Compositions useful for treating disorders related to kit |
15 Oct, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ayvakit's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List